Open Label Study of DS-5573a

NCT02192567 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

19

Enrollment

INDUSTRY

Sponsor class

Stopped Business decision

Conditions

Advanced Solid Malignant Tumors

Interventions

DRUG: DS-5573a

Sponsor

Daiichi Sankyo Co., Ltd.